FI961172A0 - Antineoplastisina aineina käyttökelpoiset 5-(1-fluorivinyyli)-1H-pyrimidiini-2,4-dionijohdannaiset - Google Patents

Antineoplastisina aineina käyttökelpoiset 5-(1-fluorivinyyli)-1H-pyrimidiini-2,4-dionijohdannaiset

Info

Publication number
FI961172A0
FI961172A0 FI961172A FI961172A FI961172A0 FI 961172 A0 FI961172 A0 FI 961172A0 FI 961172 A FI961172 A FI 961172A FI 961172 A FI961172 A FI 961172A FI 961172 A0 FI961172 A0 FI 961172A0
Authority
FI
Finland
Prior art keywords
fluorovinyl
pyrimidine
antineoplastic agents
dione derivatives
derivatives useful
Prior art date
Application number
FI961172A
Other languages
English (en)
Swedish (sv)
Other versions
FI961172A (fi
Inventor
James Ray Mcgarthy
Donald Paul Matthews
Jeffrey Stephen Sabol
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/236,599 external-priority patent/US5512678A/en
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI961172A publication Critical patent/FI961172A/fi
Publication of FI961172A0 publication Critical patent/FI961172A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI961172A 1993-09-14 1996-03-13 Antineoplastisina aineina käyttökelpoiset 5-(1-fluorivinyyli)-1H-pyrimidiini-2,4-dionijohdannaiset FI961172A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12140593A 1993-09-14 1993-09-14
US08/236,599 US5512678A (en) 1993-09-14 1994-04-29 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
PCT/US1994/009502 WO1995007917A1 (en) 1993-09-14 1994-08-23 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents

Publications (2)

Publication Number Publication Date
FI961172A FI961172A (fi) 1996-03-13
FI961172A0 true FI961172A0 (fi) 1996-03-13

Family

ID=26819425

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961172A FI961172A0 (fi) 1993-09-14 1996-03-13 Antineoplastisina aineina käyttökelpoiset 5-(1-fluorivinyyli)-1H-pyrimidiini-2,4-dionijohdannaiset

Country Status (16)

Country Link
EP (1) EP0719271B1 (fi)
JP (1) JPH09509137A (fi)
CN (1) CN1042429C (fi)
AT (1) ATE160571T1 (fi)
AU (1) AU690579B2 (fi)
CA (1) CA2170608C (fi)
DE (1) DE69407056T2 (fi)
DK (1) DK0719271T3 (fi)
ES (1) ES2111330T3 (fi)
FI (1) FI961172A0 (fi)
GR (1) GR3026075T3 (fi)
HU (1) HUT73414A (fi)
IL (1) IL110919A0 (fi)
NO (1) NO306348B1 (fi)
NZ (1) NZ273161A (fi)
WO (1) WO1995007917A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
DE10313035A1 (de) * 2003-03-24 2004-10-07 Resprotect Gmbh Methode zur Verstärkung der apoptotischen Wirkung von Zytostatika ohne Erhöhung toxischer Nebenwirkungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383990A (en) * 1980-10-01 1983-05-17 Beecham Group Limited Antiviral agents, their preparation and use
US5116823A (en) * 1990-02-27 1992-05-26 Roger Williams General Hospital Drug combinations containing AZT
FR2659330B1 (fr) * 1990-03-09 1994-02-11 Sapec Sa Composes diastereoisomeres derivant de l'acide tetrahydrofolique, procede de preparation et utilisation dans la synthese de diastereomeres 6s et 6r de folates reduits.

Also Published As

Publication number Publication date
DK0719271T3 (da) 1997-12-29
AU690579B2 (en) 1998-04-30
ATE160571T1 (de) 1997-12-15
FI961172A (fi) 1996-03-13
IL110919A0 (en) 1994-11-28
CA2170608A1 (en) 1995-03-23
CN1130909A (zh) 1996-09-11
CN1042429C (zh) 1999-03-10
WO1995007917A1 (en) 1995-03-23
NO961027L (no) 1996-03-13
GR3026075T3 (en) 1998-05-29
NO306348B1 (no) 1999-10-25
DE69407056T2 (de) 1998-04-09
NZ273161A (en) 1997-11-24
AU7636394A (en) 1995-04-03
ES2111330T3 (es) 1998-03-01
DE69407056D1 (en) 1998-01-08
EP0719271B1 (en) 1997-11-26
CA2170608C (en) 1999-03-30
JPH09509137A (ja) 1997-09-16
NO961027D0 (no) 1996-03-13
HUT73414A (en) 1996-07-29
EP0719271A1 (en) 1996-07-03
HU9600644D0 (en) 1996-05-28

Similar Documents

Publication Publication Date Title
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
HUP9802304A2 (hu) Piridazin-3-on-származékok, intermedierjeik, alkalmazásuk, a vegyületeket hatóanyagként tartalmazó herbicid készítmények
DE3781716D1 (de) Mittel zur ortsspezifischen alkylierung.
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
AP1555A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
DK0719271T3 (da) 5-(1-Fluorvinyl)-1H-pyrimidin-2,4-dion-derivater som antineoplastiske midler
BG101601A (en) Pharmaceutical piperazine compounds
DK415789D0 (da) Tetracykliske antidepressive midler
TR199700354A2 (xx) Karbohidrat t�revleri.
MEP17408A (en) N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
HUP0001010A2 (hu) Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
YU78001A (sh) Derivati 6-(((aril i heteroaril)oksi)metil) naftalen-2- karboksimidamida, njihovo dobijanje i terapeutska primena
TR200000057T2 (tr) 6-pirolidin-2-ilpirindinler, hazırlanmaları ve terapötik uygulamaları.
DK0596917T3 (da) Benzimidazolanthelmintika
ATE123025T1 (de) 2-amino-n-(((4-(aminocarbonyl)pyrimidin-2- yl>amino>alkyl>-pyrimidin-4- carbonsäureamidderivate, ihre herstellung und ihre anwendung in der therapeutica.
IL84300A0 (en) 1-carbamoyl-2-pyrazoline derivatives,their preparation and their use as herbicides
KR950026862A (ko) 벤조일 우레아 유도체
DK1230223T3 (da) Oligobenzimidazolderivater og deres anvendelse som midler til DNA-transfektion
ES8604148A1 (es) Un metodo para preparar compuestos de 1,4-dihidropiridina